Answers are grounded in this paper and cite their sources.
Introduction: ACE2 and TMPRSS2 are two crucial proteins of host cell membrane helping SARSCoV-2 viral infection to cause COVID-19 disease. ACE2 is a receptor for binding of the viral spike (S) protein and TMPRSS2 following cleaves the S protein at the S1/S2 and S'2 sites for membrane fusion.Aim: This study aimed to evaluate the expression of nasopharyngeal ACE2 and TMPRSS2 upon admission in relationship with the subsequent clinical course during hospitalization of COVID-19 patients.Material and methods: Representative 29 and 23 nasopharyngeal fluid samples collected upon admission from typical severe and mild COVID-19 patients hospitalized in the National Hospital for Tropical Diseases (Vietnam), respectively, were relatively compared RNA expression of ACE2 and TMPRSS2 by using Realtime-PCR with specific primers. SARS-CoV-2 cases were diagnosed clinically,blood and biochemical parameter, X-ray/CT and confirmed by RT-PCR.Results: The RNA expression of TMPRSS2 was relative higher (1.36 fold) in severe group in comparison with mild patients (p = 0.0004), but the level of ACE2 expression was no difference between two groups.Conclusion: TMPRSS2 but not ACE2 gene expression in the nasopharyngeal mucosa may promote the severity of COVID-19 patients but requires further study in larger samples.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: